@article {1117,
	title = {Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.},
	journal = {Journal of acquired immune deficiency syndromes (1999)},
	volume = {54},
	year = {2010},
	month = {2010 Aug},
	pages = {511-4},
	abstract = {This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX.},
	keywords = {Adult, Analgesics, Opioid, Anti-HIV Agents, Buprenorphine, Drug Interactions, Female, HIV Infections, Humans, Lopinavir, Male, Metabolic Clearance Rate, Middle Aged, Naloxone, Pyrimidinones, Ritonavir},
	issn = {1944-7884},
	doi = {10.1002/hpm.1029},
	author = {Bruce, Robert Douglas and Altice, Frederick L and Moody, David E and Morse, Gene D and Andrews, Laurie and Lin, Shen-Nan and Fang, Wenfang B and Ma, Qing and Friedland, Gerald H}
}
